Document Classification

Section Type: RESULTS

Text: Aspirin reduced the rate of the two prespecified secondary composite outcomes : the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34 % (a rate of 8. 0 % per year with placebo vs. 5. 2 % per year with aspirin ; hazard ratio with aspirin, 0. 66 ; 95 % CI, 0. 48 to 0. 92 ; P = 0. 01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33 % (hazard ratio, 0. 67 ; 95 % CI, 0. 49 to 0. 91 ; P = 0. 01).